Séverine Guillemaut

Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial

Hans Gelderblom, Claire Cropet, Christine Chevreau et al. · The Lancet Oncology · 2018 · 115 citations

Medicine, Clinical Sciences, Dermatology +10

Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay

Estelle Verronèse, Ana Sofia Delgado, Jenny Valladeau‐Guilemond et al. · OncoImmunology · 2015 · 75 citations · Full text

Life Sciences, Immunology, Oncology +16

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial

Jean‐Pierre Lotz, B. Bui, F. Gómez et al. · Annals of Oncology · 2005 · 57 citations · Full text

Medicine, Oncology, Pharmacology +15

Feasibility of an exercise and nutritional intervention for weight management during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial

Aude-Marie Foucaut, Magali Morelle, Anne-Sophie Kempf-Lépine et al. · Supportive Care in Cancer · 2019 · 24 citations

Medicine, Nutrition, Oncology +17

Design of a randomised controlled trial of adapted physical activity during adjuvant treatment for localised breast cancer: the PASAPAS feasibility study

Marina Touillaud, Sophie Berthouze, Éric Reynes et al. · BMJ Open · 2013 · 14 citations · Full text

Medicine, Oncology, Exercise Prescription +16